Epstein Secrets

embers of Congress and their staffs, Department of Defense officials, and personnel from military family support organizations. Secretary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University),

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

mbers of Congress and their staffs, Department of Defense officials, and personnel from military family support organizations. Secretary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University), P

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

mbers of Congress and their staffs, Department of Defense officials, and personnel from military family support organizations. Secretary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University), P

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

mbers of Congress and their staffs, Department of Defense officials, and personnel from military family support organizations. Secretary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University), P

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,